Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,205.00
-110.00 (-2.55%)
At close: Jun 27, 2025, 3:30 PM KST
-13.48%
Market Cap 64.91B
Revenue (ttm) 196.46B
Net Income (ttm) -3.08B
Shares Out 15.33M
EPS (ttm) -205.41
PE Ratio n/a
Forward PE n/a
Dividend 75.00 (1.77%)
Ex-Dividend Date Dec 27, 2024
Volume 240,364
Average Volume 281,594
Open 4,300.00
Previous Close 4,315.00
Day's Range 4,190.00 - 4,340.00
52-Week Range 3,070.00 - 6,130.00
Beta 0.69
RSI 46.53
Earnings Date n/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.